Literature DB >> 8418235

CPT-11-induced cholinergic effects in cancer patients.

D Gandia, D Abigerges, J P Armand, G Chabot, L Da Costa, M De Forni, A Mathieu-Boue, P Herait.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8418235     DOI： 10.1200/JCO.1993.11.1.196

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  17 in total

Review 1.  Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer.

Authors:  F G Jansman; D T Sleijfer; J C de Graaf; J L Coenen; J R Brouwers
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Clinical pharmacokinetics of irinotecan.

Authors:  G G Chabot
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

3.  Predictive factors for the development of irinotecan-related cholinergic syndrome using ordered logistic regression analysis.

Authors:  Yuko Kanbayashi; Takeshi Ishikawa; Motohiro Kanazawa; Yuki Nakajima; Yusuke Tabuchi; Rumi Kawano; Tomoko Yoshioka; Naohisa Yoshida; Toyoshi Hosokawa; Koichi Takayama; Tetsuya Taguchi
Journal:  Med Oncol       Date:  2018-04-28       Impact factor: 3.064

4.  Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan.

Authors:  C Blandizzi; B De Paolis ; R Colucci; G Lazzeri; F Baschiera; M Del Tacca
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 5.  Benefit-risk assessment of irinotecan in advanced colorectal cancer.

Authors:  Bengt Glimelius
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 6.  The role of irinotecan in colorectal cancer.

Authors:  L B Saltz
Journal:  Curr Oncol Rep       Date:  1999       Impact factor: 5.075

7.  St. John's Wort modulates the toxicities and pharmacokinetics of CPT-11 (irinotecan) in rats.

Authors:  Zeping Hu; Xiaoxia Yang; Paul Chi-Liu Ho; Eli Chan; Sui Yung Chan; Congjian Xu; Xiaotian Li; Yi-Zhun Zhu; Wei Duan; Xiao Chen; Min Huang; Hongyuan Yang; Shufeng Zhou
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

Review 8.  Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.

Authors:  Umang Swami; Sanjay Goel; Sridhar Mani
Journal:  Curr Drug Targets       Date:  2013-06       Impact factor: 3.465

Review 9.  Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.

Authors:  Jörg T Hartmann; Hans-Peter Lipp
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

10.  A risk-benefit assessment of irinotecan in solid tumours.

Authors:  L L Siu; E K Rowinsky
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.